Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III Halaven study in new breast cancer indication does not meet primary endpoints

July 10, 2012

DNAzyme is effective in models of skin cancer

July 10, 2012

OncoSec launches new phase II OMS ElectroImmunotherapy trial

July 10, 2012

First-in-human study of EP-100 complete

July 10, 2012

New agents for cancer reported by Kasina Laila Innova Pharmaceuticals

July 10, 2012

PARP-1/2 inhibitor shows promising safety profile in patients with cancer

July 10, 2012

Medigene grants exclusive EndoTAG-1 rights to SynCore

July 9, 2012

FDA approves first KRAS companion diagnostic test and Erbitux for new indication

July 9, 2012

New candidate cancer therapeutics designed at CSIR

July 9, 2012

Siena Biotech patents new SMO receptor antagonists

July 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...